(Q40749345)

English

Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7.

scientific article published on January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7. (English)

1 reference

Europe PubMed Central

23 September 2017

human papillomavirus 16

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

based on heuristic

inferred from title

4

object named as

Wilschut J

1 reference

Europe PubMed Central

23 September 2017

author name string

Daemen T

1

1 reference

Europe PubMed Central

23 September 2017

Regts J

2

1 reference

Europe PubMed Central

23 September 2017

Holtrop M

3

1 reference

Europe PubMed Central

23 September 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

23 September 2017

1 reference

Europe PubMed Central

23 September 2017

9

1 reference

Europe PubMed Central

23 September 2017

85-94

1 reference

Europe PubMed Central

23 September 2017

2

1 reference

Europe PubMed Central

23 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301627

0 references

High Frequency of Latent and Clinical Human Papillomavirus Cervical Infections in Immunocompromised Human Immunodeficiency Virus-Infected Women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Semliki Forest virus expression system: production of conditionally infectious recombinant particles.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Activation of peritoneal cells upon in vivo transfection with a recombinant alphavirus expressing GM-CSF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

E7-specific cytotoxic T cell tolerance in HPV-transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

The Semliki Forest virus vector induces p53-independent apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Semliki Forest virus-based DNA expression vector: transient protein production followed by cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Building better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Cancer therapy using a self-replicating RNA vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

A general purification protocol for E7 proteins from "high- and low-risk" human papillomavirus types expressed in the yeast Schizosaccharomyces pombe

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

A new foreign policy: MHC class I molecules monitor the outside world

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Importance of CD4(+) T helper cell responses in tumor immunity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Get into the groove! Targeting antigens to MHC class II.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Construction and characterization of recombinant VLPs and Semliki-Forest virus live vectors for comparative evaluation in the SHIV monkey model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Cloning of E6 and E7 genes of human papilloma virus type 18 and transformation potential of E7 gene and its mutants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

The short arm of chromosome 11 likely is involved in the regulation of the human papillomavirus type 16 early enhancer-promoter and in the suppression of the transforming activity of the viral DNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Quantification of antigen specific CD8+ T cells using an ELISPOT assay.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Induction of Cytotoxic T Lymphocytes With Dendritic Cells Transfected With Human Papillomavirus E6 and E7 RNA: Implications for Cervical Cancer Immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

21 January 2018

Human papillomavirus type 16 E7 oncoprotein expressed in peripheral epithelium tolerizes E7-directed cytotoxic T-lymphocyte precursors restricted through human (and mouse) major histocompatibility complex class I alleles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-helper RNA system for production of recombinant Semliki forest virus particles.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301627

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3301627

1 reference

Europe PubMed Central

23 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

23 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40749345&oldid=2043439239"